You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 1, January 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (53)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Psychosocial Issues
 •Melanoma
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Malignant Melanoma

Effects of a Brief, Structured Psychiatric Intervention on Survival and Recurrence at 10-Year Follow-up

Fawzy I. Fawzy, MD; Andrea L. Canada, PhD; Nancy W. Fawzy, RN, DNSc

Arch Gen Psychiatry. 2003;60:100-103.

Background  The influence of psychiatric intervention on cancer outcome remains a topic of considerable debate. We previously reported the survival benefits for 68 patients with malignant melanoma 5 to 6 years following their participation in a structured psychiatric group intervention. In this article, we report the effects of the intervention on disease outcome in these same patients at the 10-year follow-up.

Methods  In this univariate analysis, the survival and recurrence distributions for the intervention and control groups were estimated using the Kaplan-Meier method, and were tested for equality by the log-rank test. The multivariate analysis used the Cox proportional hazards regression model with the following prognostic factors: age, sex, Breslow depth, tumor site, and treatment status (ie, intervention group vs control group).

Results  When analyzed as single covariates, differences between the intervention and control groups were not significant for outcome at the 10-year follow-up. However, being male and having a greater Breslow depth were predictive of poorer outcome. Analysis of multiple covariates also revealed that sex and Breslow depth were significant for recurrence and survival. In addition, participation in the intervention was significant for survival. After adjusting for sex and Breslow depth, participation in the intervention remained significant for survival.

Conclusions  These findings suggest that the survival benefit of the intervention has weakened since the 5- to 6-year follow-up; however, it has not entirely disappeared. At the 10-year follow-up, participation in the intervention remained predictive of survival when statistically controlling for the effects of other known prognostic indicators. Despite the potential health benefits, we do not propose that psychiatric intervention be used in lieu of standard medical care, but as one of its integral components.


From the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, University of California, Los Angeles (Dr F. Fawzy); Department of Behavioral Sciences, M. D. Anderson Cancer Center, University of Texas, Houston (Dr Canada); John Wayne Cancer Institute, St John's Health Center, Santa Monica, Calif (Dr N. Fawzy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Stress and Stress Management Among Youth and Young Men
Vo and Park
Am J Mens Health 2008;2:353-366.
 

Letting Go of the Hope That Psychotherapy Prolongs Cancer Survival
Kissane
JCO 2007;25:5689-5690.
FULL TEXT  

Survival After a Psychoeducational Intervention for Patients With Cutaneous Malignant Melanoma: A Replication Study
Boesen et al.
JCO 2007;25:5698-5703.
ABSTRACT | FULL TEXT  

Neuroendocrine Modulation of Signal Transducer and Activator of Transcription-3 in Ovarian Cancer
Landen et al.
Cancer Res. 2007;67:10389-10396.
ABSTRACT | FULL TEXT  

Does Psychotherapy Extend Survival? Some Methodological Problems Overlooked
Coyne and Palmer
JCO 2007;25:4852-4853.
FULL TEXT  

Impact of Psychotherapeutic Support for Patients With Gastrointestinal Cancer Undergoing Surgery: 10-Year Survival Results of a Randomized Trial
Kuchler et al.
JCO 2007;25:2702-2708.
ABSTRACT | FULL TEXT  

Depression and Risk of Cancer Progression: An Elusive Link
Irwin
JCO 2007;25:2343-2344.
FULL TEXT  

Role of Depression As a Predictor of Mortality Among Cancer Patients After Stem-Cell Transplantation
Prieto et al.
JCO 2005;23:6063-6071.
ABSTRACT | FULL TEXT  

Psychoeducational Intervention for Patients With Cutaneous Malignant Melanoma: A Replication Study
Boesen et al.
JCO 2005;23:1270-1277.
ABSTRACT | FULL TEXT  

Support Groups in Breast Cancer: When a Negative Result Is Positive
Goodwin
JCO 2004;22:4244-4246.
FULL TEXT  

Group and Individual Treatment Strategies for Distress in Cancer Patients
Clark et al.
Mayo Clin Proc. 2003;78:1538-1543.
ABSTRACT  

Stress-Related Mediators Stimulate Vascular Endothelial Growth Factor Secretion by Two Ovarian Cancer Cell Lines
Lutgendorf et al.
Clin. Cancer Res. 2003;9:4514-4521.
ABSTRACT | FULL TEXT  

Excellence in Oncologic Care: Passion, Priority, and Performance
Johnson
Arch Dermatol 2003;139:1130-1132.
FULL TEXT  

OTHER ARTICLES NOTED (24 Jan 03 to 18 Apr 03)
Evid. Based Nurs. 2003;6:e1-12.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.